Home › Cancer (all types) › Louisiana › Shreveport
Cancer (all types) clinical trials in Shreveport, LA
5 studies for Cancer (all types) are looking for participants at sites in and around Shreveport (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Registry Study for Radiation Therapy Outcomes
RecruitingObservational study
- Willis-Knighton Cancer and Proton Therapy Center, Shreveport
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
RecruitingPhase 2
- TRIALS 365 ( Site 0022), Shreveport
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- LSU Health Shreveport, Shreveport
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
RecruitingPhase 3
- Trials365 LLC, Shreveport
Caris Biorepository Research Protocol
RecruitingObservational studyHealthy volunteers welcome
- CHRISTUS - Highland Medical Center, Shreveport
About Cancer (all types)
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
More about Cancer (all types) on MedlinePlus
Cancer (all types) trials in other cities
- Houston, TX121 studies
- New York City, NY109 studies
- Boston, MA85 studies
- Los Angeles, CA74 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Washington, DC58 studies
- Durham, NC58 studies
- Chicago, IL51 studies
- Atlanta, GA49 studies
- Seattle, WA49 studies
- Arlington, VA48 studies
Other studies in Shreveport
- Breast Cancer8 studies
- Endometrial Cancer7 studies
- Ovarian Cancer7 studies
- Obesity7 studies
- Non-Small Cell Lung Cancer6 studies
- COPD5 studies
- Heart Failure4 studies
- Overweight4 studies
- Multiple Myeloma4 studies
- Cardiovascular Disease4 studies
- Steatotic Liver Disease3 studies
- Pneumococcal Infections3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.